Item Type |
Article |
ID |
|
Preview |
Image |
|
Caption |
|
|
Full text |
KAKEN_17K09961seika.pdf
Type |
:application/pdf |
Download
|
Size |
:248.6 KB
|
Last updated |
:Mar 5, 2021 |
Downloads |
: 616 |
Total downloads since Mar 5, 2021 : 616
|
|
Release Date |
|
Title |
Title |
同種造血細胞移植後ヒトヘルペスウイルス6型再活性化の免疫機構の解明と予防法の確立
|
Kana |
ドウシュ ゾウケツ サイボウ イショクゴ ヒト ヘルペス ウイルス 6ガタ サイカッセイカ ノ メンエキ キコウ ノ カイメイ ト ヨボウホウ ノ カクリツ
|
Romanization |
Dōshu zōketsu saibō ishokugo hito herupesu uirusu 6gata saikasseika no men'eki kikō no kaimei to yobōhō no kakuritsu
|
|
Other Title |
Title |
Human Herpes Virus 6 reactivation after allogeneic stem cell transplantation
|
Kana |
|
Romanization |
|
|
Creator |
Name |
山崎, 理絵
|
Kana |
ヤマザキ, リエ
|
Romanization |
Yamazaki, Rie
|
Affiliation |
慶應義塾大学・医学部 (信濃町) ・助教
|
Affiliation (Translated) |
|
Role |
Research team head
|
Link |
科研費研究者番号 : 80365262
|
Name |
中山, 瞳
|
Kana |
ナカヤマ, ヒトミ
|
Romanization |
Nakayama, Hitomi
|
Affiliation |
|
Affiliation (Translated) |
|
Role |
Collaborator
|
Link |
|
Name |
|
Kana |
|
Romanization |
|
Affiliation |
|
Affiliation (Translated) |
|
Role |
|
Link |
|
|
Edition |
|
Place |
|
Publisher |
|
Date |
Issued (from:yyyy) |
2020
|
Issued (to:yyyy) |
|
Created (yyyy-mm-dd) |
|
Updated (yyyy-mm-dd) |
|
Captured (yyyy-mm-dd) |
|
|
Physical description |
|
Source Title |
Name |
科学研究費補助金研究成果報告書
|
Name (Translated) |
|
Volume |
|
Issue |
|
Year |
2019
|
Month |
|
Start page |
|
End page |
|
|
ISSN |
|
ISBN |
|
DOI |
|
URI |
|
JaLCDOI |
|
NII Article ID |
|
Ichushi ID |
|
Other ID |
|
Doctoral dissertation |
Dissertation Number |
|
Date of granted |
|
Degree name |
|
Degree grantor |
|
|
Abstract |
同種移植患者34例の血漿中のHHV-6DNA量をデジタルPCR及びリアルタイムPCRで測定し、CD4+ T細胞におけるCD134 (HHV-6特異的受容体) 発現率とHHV-6再活性化の関連を前向きに検討した。HHV-6再活性化群では非再活性化群に比し移植前のCD4+ T細胞におけるCD134発現率 (CD134/CD4比) が有意に高値だった (3.8% vs 1.5%, P<0.01) 。多変量解析にて移植前CD134/CD4比高値 (odds比=10.5, P=0.03) と臍帯血を含むHLA不適合移植 (odds比=15.4, P=0.04) がHHV-6再活性化のリスク因子であることを示した。
We prospectively evaluated the relationship between HHV-6 reactivation and CD134+ T cells in the recipients of allo-HSCT.
HHV-6 viral load in plasma was quantitatively measured weekly after allo-HSCT by digital PCR in 34 patients. The ratio of CD134 in CD4+ T cells (CD134/CD4 ratio) was serially measured by flow cytometry before and after HSCT. The CD134/CD4 ratio before HSCT was significantly higher in patients with HHV-6 reactivation than in those without (median, 3.8% vs 1.5%, P<0.01). In the multivariate analysis, a higher CD134/CD4 ratio before conditioning (odds ratio [OR], 10.5, P=0.03) and a stem cell source from an HLA-mismatched donor (OR, 15.4, P=0.04) remained as significant factors associated with HHV-6 reactivation.
|
|
Table of contents |
|
Keyword |
|
NDC |
|
Note |
研究種目 : 基盤研究 (C) (一般)
研究期間 : 2017~2019
課題番号 : 17K09961
研究分野 : 造血幹細胞移植
|
|
Language |
|
Type of resource |
|
Genre |
|
Text version |
|
Related DOI |
|
Access conditions |
|
Last modified date |
|
Creation date |
|
Registerd by |
|
History |
|
Index |
|
Related to |
|